| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
American Experience in Harmonizing National Policy
|
Peter, G.
|
|
1994
|
22 |
4 |
p. 419-421
3 p.
|
artikel
|
| 2 |
Are Different Combined Vaccines Needed in Different Parts of Europe?
|
Rümke, H.C.
|
|
1994
|
22 |
4 |
p. 425-427
3 p.
|
artikel
|
| 3 |
Bivalent Vaccines Against Bacterial Enteropathogens: Construction of Live Attenuated Vaccine Strains With Two O-Serotype Specificities
|
Viret, J-F.
|
|
1994
|
22 |
4 |
p. 361-372
12 p.
|
artikel
|
| 4 |
Booster Doses and Combined Vaccines
|
Dittmann, S.
|
|
1994
|
22 |
4 |
p. 433-434
2 p.
|
artikel
|
| 5 |
Clinical Evaluation of HB Vaccine as a Component of Combination Vaccines
|
Kane, Mark A.
|
|
1994
|
22 |
4 |
p. 403-405
3 p.
|
artikel
|
| 6 |
Combination of DTP and Haemophilus influenzae Type b Conjugate Vaccines can Affect Laboratory Evaluation of Potency and Immunogenicity
|
Redhead, Keith
|
|
1994
|
22 |
4 |
p. 339-345
7 p.
|
artikel
|
| 7 |
Combination Vaccines: Present Practices and Future Possibilities
|
Ada, Gordon
|
|
1994
|
22 |
4 |
p. 329-331
3 p.
|
artikel
|
| 8 |
Combined Vaccines: Policy and Practice in the European Pharmacopoeia
|
Castle, P.
|
|
1994
|
22 |
4 |
p. 381-387
7 p.
|
artikel
|
| 9 |
Combined Vaccines—The European Contribution
|
Glück, R.
|
|
1994
|
22 |
4 |
p. 347-351
5 p.
|
artikel
|
| 10 |
Conclusions of Workshop I
|
|
|
1994
|
22 |
4 |
p. 388-
1 p.
|
artikel
|
| 11 |
Conclusions of Workshop II
|
|
|
1994
|
22 |
4 |
p. 409-410
2 p.
|
artikel
|
| 12 |
Conclusions of Workshop III
|
|
|
1994
|
22 |
4 |
p. 435-436
2 p.
|
artikel
|
| 13 |
Control Testing of Combined Vaccines: A Consideration of Potential Problems and Approaches
|
Corbel, Michael J.
|
|
1994
|
22 |
4 |
p. 353-360
8 p.
|
artikel
|
| 14 |
Cost Benefit of Combining Antigens
|
Hadler, Stephen C.
|
|
1994
|
22 |
4 |
p. 415-418
4 p.
|
artikel
|
| 15 |
Definition of Acceptable Levels for Safety and Potential Problems
|
Salmaso, S.
|
|
1994
|
22 |
4 |
p. 407-408
2 p.
|
artikel
|
| 16 |
Definition of Minimum Standards for Immunogenicity—Potential Problems of Serological Correlates—Possible Interference
|
Heron, I.
|
|
1994
|
22 |
4 |
p. 389-390
2 p.
|
artikel
|
| 17 |
Development of Combined Vaccines: Manufacturers' Viewpoint
|
André, F.E.
|
|
1994
|
22 |
4 |
p. 317-321
5 p.
|
artikel
|
| 18 |
Difficulties in Establishing a Serological Correlate of Protection After Immunization with Haemophilus Influenzae Conjugate Vaccines
|
Käyhty, H.
|
|
1994
|
22 |
4 |
p. 397-402
6 p.
|
artikel
|
| 19 |
Epidemiological Views into Possible Components of Paediatric Combined Vaccines in 2015
|
Eskola, Juhani
|
|
1994
|
22 |
4 |
p. 323-327
5 p.
|
artikel
|
| 20 |
Immunisation Policies and Programmes in Europe
|
Salisbury, David
|
|
1994
|
22 |
4 |
p. 313-315
3 p.
|
artikel
|
| 21 |
Immunogenicity of Acellular Pertussis Vaccines
|
Hallander, H.
|
|
1994
|
22 |
4 |
p. 391-395
5 p.
|
artikel
|
| 22 |
Inclusion of IPV in Combined Vaccines
|
Hovi, T.
|
|
1994
|
22 |
4 |
p. 431-432
2 p.
|
artikel
|
| 23 |
Integration of Hepatitis B and Hib Vaccine in National Vaccination Programmes in Southern Europe
|
Papaevangelou, G.
|
|
1994
|
22 |
4 |
p. 429-430
2 p.
|
artikel
|
| 24 |
Opening Address
|
Baudrihaye, N.
|
|
1994
|
22 |
4 |
p. 297-298
2 p.
|
artikel
|
| 25 |
Pertussis in Combined Vaccines
|
Trollfors, B.
|
|
1994
|
22 |
4 |
p. 423-424
2 p.
|
artikel
|
| 26 |
Pharmaceutical Aspects of Combined Vaccines: A Manufacturer's Perspective
|
Vose, J.R.
|
|
1994
|
22 |
4 |
p. 335-338
4 p.
|
artikel
|
| 27 |
Problems in the Choice of Combined Vaccines for Europe
|
Plotkin, Stanley A.
|
|
1994
|
22 |
4 |
p. 411-414
4 p.
|
artikel
|
| 28 |
Regulatory Framework of Immunologicals in the European Union
|
Sauer, F.
|
|
1994
|
22 |
4 |
p. 307-311
5 p.
|
artikel
|
| 29 |
Role of the European Commission in Pharmaceuticals Research
|
Fracchia, G.N.
|
|
1994
|
22 |
4 |
p. 333-334
2 p.
|
artikel
|
| 30 |
Stability Testing on Vaccines—Results of Activities of the International Conference on Harmonization (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use
|
Haase, M.
|
|
1994
|
22 |
4 |
p. 373-375
3 p.
|
artikel
|
| 31 |
The System of Mutual Recognition of Batch Release in the EU—Implications for Combined Vaccines
|
Dobbelaer, R.
|
|
1994
|
22 |
4 |
p. 377-380
4 p.
|
artikel
|
| 32 |
Welcome Address
|
Tarlow, M.
|
|
1994
|
22 |
4 |
p. 301-
1 p.
|
artikel
|
| 33 |
Welcome Address
|
Stéphenne, Jean
|
|
1994
|
22 |
4 |
p. 303-306
4 p.
|
artikel
|
| 34 |
Welcome Address
|
Sauer, F.
|
|
1994
|
22 |
4 |
p. 299-300
2 p.
|
artikel
|
Tijdschrift beschrijving